OxyContin marketer agrees to pay $350M rather than face lawsuits
Indiana will receive more than $7.6 million from the settlement with Publicis Health to help address the opioid crisis.
Health Care & Insurance
Articles
Lilly factory in New Jersey comes under more federal scrutiny
Lilly said it was working closely with the FDA and the “situation does not affect the quality, safety or supply of any current or planned Lilly products in the marketplace.”
Indiana Senate panel advances bill loosening medical prior authorizations
The bill would would prohibit health insurers from requiring prior authorization for routine medical services, federally approved prescription drugs, emergency health care and other services.
Avoid local emergency rooms for mild illness, health department urges
Hospitals in Marion County have reported a surge in patients, placing many of them at capacity, the health department said.
Odd bedfellows Mike Braun and Bernie Sanders team up to support health price transparency
The conservative Braun and the liberal Sanders might have more in common that meets the eye, with a growing list of issues they have both supported.
Health-tech startup DecisionRx lands $100M credit facility to fund growth
Indianapolis-based DecisionRx uses technology to recommend medication decisions to physicians and pharmacists based on genetic profiles, existing medication regimes and contraindications.
Indiana Senate Republicans prioritize literacy, health in five-part agenda
A bill to require earlier interventions for students struggling with literacy is top-of-list for Indiana Senate Republicans, who unveiled their 2024 agenda Thursday morning.
Jane Pauley Community Health Center takes over 7 medical practices
The locations include six pediatric practices and one OB/GYN practice in Anderson, Greenwood, Indianapolis and Kokomo.
J&J to pay $700M to settle states’ talc-marketing probe
The settlement is part of J&J’s strategy to corral a growing number of suits accusing it of concealing baby powder’s health risks after two failed attempts to use the bankruptcy courts to impose a settlement on former users.
Novartis gets green light for production of cancer drug in Indy
The 70,000-square-foot facility near Indianapolis International Airport will be used to make Pluvicto, which is used to treat advanced-stage prostate cancer who have run out of treatment options.
Elevance Health buys Texas-based chain of infusion centers
Paragon Healthcare Inc., based in suburban Dallas, serves more than 35,000 patients with a broad range of acute and chronic conditions at more than 40 ambulatory infusion centers across eight southern and western states, as well as in patients’ homes.
More hospitals requiring masks as flu, COVID cases surge
While experts say this season likely won’t prove to be as deadly as some other recent winters, it still could mean hundreds of thousands of hospitalizations and many thousands of deaths.
Nevada company sues Lilly for breach of contract over Alzheimer’s drug
Lilly called the lawsuit “baseless” and said PDL BioPharma “has no plausible claim to royalties” for donanemab, which is expected to be approved by the FDA this quarter.
RayzeBio Inc. to be acquired by drugmaker Bristol Myers Squibb for $4.1B
RayzeBio is building a large factory on the northwest side of Indianapolis to make radioisotopes for cancer treatment.
Drugmakers delay in-demand medicines to evade Biden’s new pricing rules
Firms that normally try to sell drugs as soon as possible are suspending clinical trials and shifting timelines, while patient groups are demanding change.
Families say autism therapy helped their kids, but Indiana’s Medicaid cuts could put it out of reach
Providers of the therapy say the new rates are not enough to keep them running and are far below the previous statewide average of $97 per hour.
Kim and Tom Saxton: The myths that hold back health care innovation
Innovating in health care is not just hard and expensive—it is REALLY hard and expensive.
Lilly stock slips after study finds patients who stop Zepbound regain weight
People who stopped taking Eli Lilly and Co.’s blockbuster drug Zepbound after about eight months regained half the weight they’d lost a year later, yet were significantly thinner than when they had started the obesity drug, according to a new study.
Nurses at IU Health’s University, Methodist hospitals eye unionizing
The Indianapolis-based nurses cite poor staffing ratios, patient care and wages as some of the driving reasons behind their efforts.
Up to 5.4M people in U.S. already have had the flu this season
The Centers for Disease Control and Prevention also estimates that flu has caused as many as 55,000 hospitalizations and 4,600 deaths from Oct. 1 through Dec. 2.